Bleeding News and Research

RSS

Strokes will cost U.S. $2.2 trillion over the next 45 years

Strokes will cost U.S. $2.2 trillion over the next 45 years

Unless Americans do more to lower their risk of stroke and improve stroke care, the nation will pay $2.2 trillion over the next 45 years to care for people who suffer the most common form of stroke, a new University of Michigan study predicts.

16 Aug 2006

Breast cancer sufferers experience more side effects from chemo than previously thought

Breast cancer sufferers experience more side effects from chemo than previously thought

Women with breast cancer ages 64 and younger experience three to four times more serious side effects from chemotherapy than previously hypothesized, according to a study published in the Aug. 16 edition of the Journal of the National Cancer Institute, the AP/Philadelphia Inquirer reports.

16 Aug 2006

Argatroban may promote opening of arteries following stroke

Argatroban may promote opening of arteries following stroke

A medication known as argatroban, when combined with another drug already used in the treatment of stroke patients, may help restore the flow of blood through blocked arteries.

14 Aug 2006

Lipitor reduces the risk of a second stroke

Lipitor reduces the risk of a second stroke

Researchers have found that the drug Lipitor which is normally used to lower cholesterol, can cut the risk of a second stroke when used in double doses.

14 Aug 2006

Older patients with atrial fibrillation have higher rates of major hemorrhage in the brain

Older patients with atrial fibrillation have higher rates of major hemorrhage in the brain

Older patients with atrial fibrillation have higher rates of major hemorrhage in the brain whether or not they are using a common blood thinning therapy, according to a new study.

3 Aug 2006

Stress reactions and perceived difficulties of lay responders to a medical emergency

Stress reactions and perceived difficulties of lay responders to a medical emergency

Even though they are trained in CPR, people hesitate to take action when an emergency unfolds in front of them. But the cause, a study has found, is more likely to be confusion than stress.

2 Aug 2006

Likelihood of hemorrhage on warfarin is relatively small

Likelihood of hemorrhage on warfarin is relatively small

Older patients with atrial fibrillation have higher rates of major hemorrhage in the brain whether or not they are using a common blood thinning therapy, according to a new study.

2 Aug 2006

Chemicals in curry and onions may help prevent colon cancer

Chemicals in curry and onions may help prevent colon cancer

A small but informative clinical trial by Johns Hopkins investigators shows that a pill combining chemicals found in turmeric, a spice used in curries, and onions reduces both the size and number of precancerous lesions in the human intestinal tract.

1 Aug 2006

COX-2 inhibitors prescribed to reduce gastrointestinal toxicity prior to the market withdrawals

COX-2 inhibitors prescribed to reduce gastrointestinal toxicity prior to the market withdrawals

Nonsteroidal anti-inflammatory drugs (NSAIDs) have been the most popular treatment for arthritis - despite their association with gastrointestinal (GI) complications, including bleeding ulcers and death.

27 Jul 2006

NICE backs use of Enbrel and Raptiva to treat severe psoriasis

NICE backs use of Enbrel and Raptiva to treat severe psoriasis

NICE has today issued guidance for the use of the targeted biological therapies, Enbrel (etanercept) and Raptiva (efalizumab), to treat adult patients with severe plaque psoriasis.

26 Jul 2006

FDA expands use of Oncaspar to include treating children and adults with newly diagnosed acute lymphoblastic leukemia

FDA expands use of Oncaspar to include treating children and adults with newly diagnosed acute lymphoblastic leukemia

The U.S. Food and Drug Administration (FDA) has expanded the approved use of Oncaspar to include treating children and adults with newly diagnosed acute lymphoblastic leukemia (ALL) as part of a multiple drug chemotherapy regimen.

25 Jul 2006

New natural contraceptive pill being trialled

New natural contraceptive pill being trialled

University of Adelaide researchers, together with the Adelaide Hormone and Menopause Centre, are trialling a new natural contraceptive pill alternative.

24 Jul 2006

Matchstick-sized contraceptive implant that lasts for three years

Matchstick-sized contraceptive implant that lasts for three years

The Food and Drug Administration in the U.S. has given approval for a new contraceptive which will protect women from pregnancy for as long as three years.

20 Jul 2006

Copper containing, framed intra-uterine devices for contraception

Copper containing, framed intra-uterine devices for contraception

Intrauterine devices that contain higher doses of copper are more effective in preventing pregnancy than IUDs with lower copper doses, according to a new systematic review of studies.

19 Jul 2006

Drugs for preventing postoperative nausea and vomiting

Drugs for preventing postoperative nausea and vomiting

Patients coming out of anesthesia after surgery may experience nausea or vomiting, and are frequently given drugs to prevent this. But the majority of patients won't benefit from these drugs, according to a large new review of studies.

19 Jul 2006

FDA approval for Gemzar for ovarian cancer

FDA approval for Gemzar for ovarian cancer

Eli Lilly and Company announced that the United States Food and Drug Administration (FDA) has approved Gemzar (gemcitabine HCl) for use in the treatment of women living with recurrent ovarian cancer.

18 Jul 2006

Female stroke risk reduced by healthy living

Female stroke risk reduced by healthy living

Researchers in America say that women can significantly reduce their risk of a stroke by adopting a healthy lifestyle.

12 Jul 2006

BioTel system to test methods of improving cardiac arrest

BioTel system to test methods of improving cardiac arrest

UT Southwestern Medical Center is among 10 institutions selected to oversee innovative clinical trials designed to test life-saving interventions for critical trauma and sudden cardiac arrest.

11 Jul 2006

Potential permanent genetic cure for hemophilia A

Potential permanent genetic cure for hemophilia A

A discovery by Medical College of Wisconsin and BloodCenter of Wisconsin researchers in Milwaukee may be a key to a permanent genetic cure for hemophilia A patients, including a subset who do not respond to conventional blood transfusions.

3 Jul 2006

FDA grants accelerated approval for Sprycel (dasatinib)

FDA grants accelerated approval for Sprycel (dasatinib)

FDA grants accelerated approval for Sprycel (dasatinib), a new oral treatment for patients with chronic myeloid leukemia (CML),

29 Jun 2006

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.